Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 55
Filter
1.
Infection ; 43(2): 185-92, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25475221

ABSTRACT

PURPOSE: Influenza A viruses, human coronaviruses (hCoV) and human bocavirus (hBoV) are emerging respiratory viruses. This study investigated the association between influenza A viruses co-infection with hBoV and hCoV and severity and the sensitivity of a real-time polymerase chain reaction (RT-PCR) assay for identification of 15 coronaviruses. METHODOLOGY: Published sequences for the 15 human coronaviruses were used to design a consensus PCR targeting the replicase open reading frame 1b. A previously published PCR targeting the NS1 Gene of all known human bocavirus strains was also utilized. A series of 217 samples from patients aged 37.7 (SD ± 30.4)] with seasonal influenza A viruses (SeasFluA) identified between 06/2011 and 06/2012 in NW England were tested for hCoV and hBoV using RT-PCR. Association between co-infection and disease outcome was assessed using logistic regression. RESULTS: The limit of detection of hCoV RT-PCR assay was 2 copies/µl of human coronavirus RNA template, a sensitivity comparable to a previously published SYBR green assay for human coronaviruses. A total of 12 hCoV and 17 hBoV were identified in the 217 influenza A positive samples. A higher proportion (61.5%; 8/13) of SeasFluA/hBoV co-infections were identified in patients that were admitted either to a general ward or the intensive care unit compared to 44.3% (66/149) of single SeasFlu A virus infections (OR 2.5 95% CI 0.67-9.34, p = 0.17). In a stratified analysis, there was a trend towards higher association between FluA, hCoV and hBoV with increasing age (especially in patients aged 24-45 years and >65 year old). CONCLUSION: Our hCoV RT-PCR protocol appeared to be of adequate analytical sensitivity for diagnosis. More and larger studies are needed to confirm the role of hCoV, hBoV in causing severe disease when they co-infect with influenza A viruses.


Subject(s)
Coronavirus Infections/diagnosis , Coronavirus/genetics , Human bocavirus/genetics , Parvoviridae Infections/diagnosis , Real-Time Polymerase Chain Reaction , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Coinfection , Coronavirus Infections/virology , Female , Hospitalization , Humans , Infant , Influenza A virus/genetics , Influenza, Human/virology , Male , Middle Aged , Odds Ratio , Parvoviridae Infections/virology , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/virology , Sensitivity and Specificity , Severity of Illness Index , Young Adult
2.
Epidemiol Infect ; 143(1): 37-47, 2015 Jan.
Article in English | MEDLINE | ID: mdl-24568719

ABSTRACT

Respiratory virus infections cause a significant number of hospitalization and deaths globally. This study investigated the association between single and multiple respiratory virus infections and risk of admission to a general ward, intensive care unit or death in patients aged 0-105 years (mean ± s.d. = 24·4 ± 24·1 years), from North West England, that were tested for respiratory virus infections between January 2007 and June 2012. The majority of infections were in children aged ⩽5 years. Dual or multiple infections occurred in 10·4% (1214/11 715) of patients, whereas single infection occurred in 89·6% (10 501/11 715). Rhinovirus was the most common co-infecting virus (occurring in 69·5%; 844/1214 of co-infections). In a multivariate logistic regression model, multiple infections were associated with an increased risk of admission to a general ward [odds ratio (OR) 1·43, 95% confidence interval (CI) 1·2-1·7, P < 0·0001]. On the other hand, patients with respiratory syncytial virus (RSV) and human parainfluenza virus types 1-3 (hPIV1-3), as a single infection, had a higher risk of being admitted to a general ward (OR 1·49, 95% CI 1·28-1·73, P < 0·0001 and OR 1·34, 95% CI 1·003-1·8, P = 0·05, respectively); admitted to an intensive-care unit or dying (OR 1·5, 95% CI 1·20-2·0, P = 0·001 and OR 1·60, 95% CI 1·02-2·40, P = 0·04, respectively). This result emphasizes the importance of RSV, hPIV and mixed infections and calls for research on vaccines, drugs and diagnostic tests targeting these respiratory viruses.


Subject(s)
Coinfection/epidemiology , Coinfection/mortality , Virus Diseases/epidemiology , Virus Diseases/mortality , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Cross-Sectional Studies , England/epidemiology , Female , Hospitalization , Humans , Infant , Infant, Newborn , Male , Middle Aged , Survival Analysis , Young Adult
3.
Arch Virol ; 159(12): 3167-83, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25078388

ABSTRACT

Mutations in the haemagglutinin (HA), non-structural protein 1 (NS1) and polymerase basic protein 2 (PB2) of influenza viruses have been associated with virulence. This study investigated the association between mutations in these genes in influenza A(H1N1)pdm09 virus and the risk of severe or fatal disease. Searches were conducted on the MEDLINE, EMBASE and Web of Science electronic databases and the reference lists of published studies. The PRISMA and STROBE guidelines were followed in assessing the quality of studies and writing-up. Eighteen (18) studies, from all continents, were included in the systematic review (recruiting patients 0 - 77 years old). The mutation D222G was associated with a significant increase in severe disease (pooled RD: 11 %, 95 % CI: 3.0 % - 18.0 %, p = 0.004) and the risk of fatality (RD: 23 %, 95 % CI: 14.0 %-31.0 %, p = < 0.0001). No association was observed between the mutations HA-D222N, D222E, PB2-E627K and NS1-T123V and severe/fatal disease. The results suggest that no virus quasispecies bearing virulence-conferring mutations in the HA, PB2 and NS1 predominated. However issues of sampling bias, and bias due to uncontrolled confounders such as comorbidities, and viral and bacterial coinfection, should be born in mind. Influenza A viruses should continue to be monitored for the occurrence of virulence-conferring mutations in HA, PB2 and NS1. There are suggestions that respiratory virus coinfections also affect virus virulence. Studies investigating the role of genetic mutations on disease outcome should make efforts to also investigate the role of respiratory virus coinfections.


Subject(s)
Hemagglutinin Glycoproteins, Influenza Virus/genetics , Influenza A Virus, H1N1 Subtype/genetics , Influenza A Virus, H1N1 Subtype/pathogenicity , Influenza, Human/pathology , Influenza, Human/virology , RNA-Dependent RNA Polymerase/genetics , Viral Nonstructural Proteins/genetics , Viral Proteins/genetics , Humans , Influenza A Virus, H1N1 Subtype/isolation & purification , Influenza, Human/mortality , Mutant Proteins/genetics , Mutation , Survival Analysis , Virulence
4.
Int J Biometeorol ; 58(9): 1845-51, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24452385

ABSTRACT

The effect of changes in the weather on the respiratory health of patients with cystic fibrosis (CF) is unclear. We conducted a prospective study to determine the impact of climate and season on the incidence of viral respiratory infections (VRI) and pulmonary exacerbations (PEx) among adults with CF. Between December 2010 and April 2012, 98 adults with CF were followed for 12 months. Polymerase chain reaction assays for nine viruses were performed on sputum, nose and throat swabs every 2 months and additionally at onset of PEx. Hourly temperature and relative humidity measurements were recorded throughout the study. Statistical analysis utilized generalized estimating equation (GEE) models. Pre-specified criteria for VRI and PEx were met at 29% and 37% of visits, respectively. Rhinovirus accounted for 72% of identified viruses. Incidence of rhinovirus peaked in autumn while non-rhinovirus VRI peaked in winter. Rhinovirus was associated with increased mean temperatures (OR 1.07; p = 0.001), while non-rhinovirus VRI was associated with lower mean temperatures (OR 0.87; p < 0.001). PEx occurred frequently throughout the study with no clear seasonal pattern observed. There was no significant association between climate variables and the incidence of either PEx or antibiotic prescription. There is a seasonal pattern to VRI in adults with CF. The incidence of VRI but not PEx is associated with changes in ambient temperature.


Subject(s)
Climate , Cystic Fibrosis/epidemiology , Respiratory Tract Infections/epidemiology , Virus Diseases/epidemiology , Weather , Adult , Comorbidity , Cystic Fibrosis/diagnosis , Female , Humans , Male , Population Surveillance , Prevalence , Risk Factors , Temperature , United Kingdom/epidemiology , Virus Diseases/diagnosis , Young Adult
5.
Epidemiol Infect ; 141(5): 916-25, 2013 May.
Article in English | MEDLINE | ID: mdl-22849968

ABSTRACT

The aim of this study was to estimate the amount of childhood hepatitis B virus transmission in children born in the UK, a very low-prevalence country, that is preventable only by universal hepatitis B immunization of infants. Oral fluid specimens were collected from schoolchildren aged 7-11 years in four inner city multi-ethnic areas and tested for the presence of antibody to hepatitis B core antigen (anti-HBc). Those found positive or indeterminate were followed up with testing on serum to confirm their hepatitis B status. The overall prevalence of anti-HBc in children was low [0.26%, 95% confidence interval (CI) 0.14-0.44]. The estimated average annual incidence of hepatitis B was estimated to be 29.26/100 000 children (95% CI 16.00-49.08). The total incidence that is preventable only by a universal infant immunization programme in the UK was estimated to be between 5.00 and 12.49/100 000. The study demonstrates that the extent of horizontal childhood hepatitis B virus transmission is low in children born in the UK and suggests that schools in the UK are an uncommon setting for the transmission of the virus. Targeted hepatitis B testing and immunization of migrants from intermediate- and high-prevalence countries is likely to be a more effective measure to reduce childhood transmission than a universal infant immunization programme.


Subject(s)
Ethnicity , Hepatitis B/epidemiology , Hepatitis B/transmission , Child , Cross-Sectional Studies , Emigrants and Immigrants , England/epidemiology , Family , Female , Hepatitis B/ethnology , Hepatitis B/prevention & control , Hepatitis B virus/immunology , Humans , Male , Population Surveillance , Surveys and Questionnaires
7.
J Clin Microbiol ; 49(10): 3576-83, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21865429

ABSTRACT

The laboratory diagnostic strategy used to determine the etiology of encephalitis in 203 patients is reported. An etiological diagnosis was made by first-line laboratory testing for 111 (55%) patients. Subsequent testing, based on individual case reviews, resulted in 17 (8%) further diagnoses, of which 12 (71%) were immune-mediated and 5 (29%) were due to infection. Seventy-five cases were of unknown etiology. Sixteen (8%) of 203 samples were found to be associated with either N-methyl-d-aspartate receptor or voltage-gated potassium channel complex antibodies. The most common viral causes identified were herpes simplex virus (HSV) (19%) and varicella-zoster virus (5%), while the most important bacterial cause was Mycobacterium tuberculosis (5%). The diagnostic value of testing cerebrospinal fluid (CSF) for antibody was assessed using 139 samples from 99 patients, and antibody was detected in 46 samples from 37 patients. Samples collected at 14 to 28 days were more likely to be positive than samples taken 0 to 6 days postadmission. Three PCR-negative HSV cases were diagnosed by the presence of virus-specific antibody in the central nervous system (CNS). It was not possible to make an etiological diagnosis for one-third of the cases; these were therefore considered to be due to unknown causes. Delayed sampling did not contribute to these cases. Twenty percent of the patients with infections with an unknown etiology showed evidence of localized immune activation within the CNS, but no novel viral DNA or RNA sequences were found. We conclude that a good standard of clinical investigation and thorough first-line laboratory testing allows the diagnosis of most cases of infectious encephalitis; testing for CSF antibodies allows further cases to be diagnosed. It is important that testing for immune-mediated causes also be included in a diagnostic algorithm.


Subject(s)
Algorithms , Clinical Laboratory Techniques/methods , Encephalitis/diagnosis , Encephalitis/etiology , Adolescent , Adult , Antibodies/cerebrospinal fluid , Bacterial Infections/diagnosis , Bacterial Infections/microbiology , Cerebrospinal Fluid/immunology , Child , Child, Preschool , Cohort Studies , Diagnosis, Differential , England , Female , Humans , Immune System Diseases/diagnosis , Male , Middle Aged , Prospective Studies , Virus Diseases/diagnosis , Virus Diseases/virology , Young Adult
8.
Epidemiol Infect ; 138(6): 783-800, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20388231

ABSTRACT

Defining the causal relationship between a microbe and encephalitis is complex. Over 100 different infectious agents may cause encephalitis, often as one of the rarer manifestations of infection. The gold-standard techniques to detect causative infectious agents in encephalitis in life depend on the study of brain biopsy material; however, in most cases this is not possible. We present the UK perspective on aetiological case definitions for acute encephalitis and extend them to include immune-mediated causes. Expert opinion was primarily used and was supplemented by literature-based methods. Wide usage of these definitions will facilitate comparison between studies and result in a better understanding of the causes of this devastating condition. They provide a framework for regular review and updating as the knowledge base increases both clinically and through improvements in diagnostic methods. The importance of new and emerging pathogens as causes of encephalitis can be assessed against the principles laid out here.


Subject(s)
Encephalitis/etiology , Acute Disease , Amebiasis/complications , Amebiasis/diagnosis , Bacterial Infections/complications , Bacterial Infections/diagnosis , Encephalitis/diagnosis , Encephalitis/microbiology , Humans , Rickettsia Infections/complications , Rickettsia Infections/diagnosis , Toxoplasmosis/complications , Toxoplasmosis/diagnosis , United Kingdom/epidemiology , Virus Diseases/complications , Virus Diseases/diagnosis
9.
Bone Marrow Transplant ; 40(1): 55-61, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17468776

ABSTRACT

The use of quantitative cytomegalovirus (CMV) real-time polymerase chain reaction (RT-PCR) and preemptive ganciclovir therapy is replacing prophylaxis as the management of choice in high-risk patients undergoing stem cell transplantation (SCT). However, there are limited data defining its role in this setting. In the current retrospective single-centre study, quantitative RT-PCR was used to determine CMV in 577 consecutive patients undergoing SCT (172 allogeneic and 405 autologous) over a 5-year period. CMV RT-PCR was performed weekly until cessation of immunosuppression (allogeneic) or for 30 days post-SCT (autologous). Treatment was commenced after two consecutive positive results or a high copy on the first occasion (> 1000 copies/ml, > 3 log). The overall CMV reactivation rate in patients undergoing allogeneic SCT was 30%, with reactivation observed in 72% of high-risk patients (recipient positive patients). CMV end-organ disease was observed in eight patients (1%); of these, four were CMV RT-PCR negative at the time of diagnosis of end-organ CMV disease, with three remaining negative throughout the course of the disease. CMV-related mortality was recorded in three patients. The current data support a preemptive treatment strategy-based CMV RT-PCR, but indicate that in symptomatic patients, a negative CMV PCR result does not exclude CMV end-organ disease.


Subject(s)
Cytomegalovirus Infections/epidemiology , Cytomegalovirus/isolation & purification , Stem Cell Transplantation/adverse effects , Viral Load , Adolescent , Adult , Aged , Cytomegalovirus/genetics , Female , Humans , Male , Middle Aged , Reproducibility of Results , Retrospective Studies , Reverse Transcriptase Polymerase Chain Reaction , Transplantation, Autologous , Transplantation, Homologous
11.
Epidemiol Infect ; 135(3): 417-26, 2007 Apr.
Article in English | MEDLINE | ID: mdl-16836798

ABSTRACT

This paper describes sentinel laboratory surveillance of hepatitis C antibody testing in England. Demographic and test result data were supplemented by follow-up questionnaires sent to the requesting clinician. Between October 2002 and September 2003 almost 75000 anti-HCV tests were performed in eight sentinel centres. More males were tested than females and over half of those tested were aged 25-44 years. Overall 5.7% (3333/58144, range 2.8-7.7%) individuals tested positive. Follow-up questionnaire data showed that 82% (1043/1277) of the positives had injecting drug use reported as the main risk exposure. The majority of negative individuals were undergoing routine screening as recommended for specific patient groups. Most individuals were asymptomatic. Antibody prevalence was estimated to be 34% in current injecting drug users and 42% in former injectors. Comparing positives to routine national surveillance suggests that only 53% (1782/3333) of diagnosed cases were reported. Sentinel laboratory data can provide valuable supplementary data to national surveillance.


Subject(s)
Hepatitis C Antibodies/blood , Hepatitis C/epidemiology , Sentinel Surveillance , Acute Disease , Adolescent , Adult , Aged , Child , Child, Preschool , England/epidemiology , Female , Follow-Up Studies , Humans , Infant , Male , Middle Aged , Surveys and Questionnaires
12.
Bone Marrow Transplant ; 36(8): 691-4, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16113671

ABSTRACT

Infective diarrhoea is common among allogeneic stem cell transplant (SCT) recipients, frequently caused by viruses and may be difficult to differentiate from acute graft-versus-host disease (GVHD). Viral pathogens may directly or indirectly impact upon transplant-related mortality. Rotavirus is one of the most common causes of diarrhoea worldwide, but one of the least studied causes of diarrhoea post SCT. In this retrospective study we describe 21 cases of confirmed rotavirus infection in allogeneic SCT recipients. Most of these cases may occur in clusters during the winter and spring period. Symptoms of rotaviral infection were diarrhoea (95%), vomiting (62%), abdominal pain (38%), weight loss and loss of appetite in 38 and 29% of the cases, respectively. Possible extraintestinal manifestations of rotavirus infection were observed. The duration of the symptoms in this series ranged from 4 days to 4 months with median of 15 days. Patients with rotavirus infection were invariably lymphopenic and/or on immunosuppression for GVHD. Of the patients diagnosed with rotavirus, 86% required hospitalisation. In 57% of the cases, other viral pathogens were isolated near to the rotavirus infection period. Rotavirus infection is an important cause of prolonged diarrhoea post SCT, causing significant morbidity and frequently requiring hospitalisation.


Subject(s)
Bone Marrow Transplantation/adverse effects , Diarrhea/virology , Leukemia/therapy , Rotavirus Infections/epidemiology , Adolescent , Adult , Child , Child, Preschool , Diarrhea/epidemiology , Humans , Infant , Lymphocyte Depletion , Morbidity , Rotavirus/classification , Rotavirus/isolation & purification , T-Lymphocytes/immunology , Transplantation, Homologous/adverse effects
13.
Bone Marrow Transplant ; 32(1): 73-7, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12815481

ABSTRACT

Respiratory virus infections are an important cause of morbidity and mortality in bone marrow transplant patients. A retrospective study was performed on the bone marrow transplant unit at the Christie Hospital Manchester. The aim of this study was to determine the frequency, clinical presentation, laboratory diagnosis, types of intervention (eg antiviral agents used) and the outcome of such infections in this cohort of transplant recipients. Data were collected from a total of 626 adult patients and showed 27 patients with 29 confirmed episodes of viral respiratory tract infections. The viruses present were rhinovirus (40%), respiratory syncytial virus (RSV) (22.2%), influenza A (18.5%), parainfluenza (PIV) (14.8%) and enteroviruses (7.4%). The overall frequency of documented respiratory virus infections was 4.3% during the 5-year period of the study. The prevalence of respiratory viral infections was 7.8% among allogeneic and 2.3% among autologous transplant recipients. The frequency of lower respiratory tract infection (LRTI) was 3.0% among allogeneic and 1.3% among autologous transplant recipients. Eight patients died (seven had allogeneic transplants). Three of these deaths were directly attributable to a respiratory viral infection (two rhinoviruses; one PIV 3). This study further supports the role played by human respiratory viruses in transplant-associated morbidity and mortality, and particularly highlights the significance of rhinovirus infections.


Subject(s)
Bone Marrow Transplantation/adverse effects , Peripheral Blood Stem Cell Transplantation/adverse effects , Respiratory Tract Infections/etiology , Adult , Aged , Antiviral Agents/therapeutic use , Cohort Studies , Female , Humans , Incidence , Male , Middle Aged , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/drug therapy , Retrospective Studies , Transplantation, Autologous , Transplantation, Homologous , Treatment Outcome , Virus Diseases/diagnosis , Virus Diseases/drug therapy , Virus Diseases/etiology
15.
J Clin Virol ; 25(1): 73-92, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12126724

ABSTRACT

A growing number of antiviral agents are available for treatment of persistent viral infections. This has increased the requirement for virology laboratories to undertake sophisticated assays for monitoring the efficacy of treatment and identifying drug failure at an early stage. The consensus guidelines within this article address the laboratory requirements for monitoring treatment of the herpes viruses, HIV-1, Hepatitis B and Hepatitis C.


Subject(s)
Clinical Laboratory Techniques/standards , Laboratories, Hospital/standards , Medical Laboratory Personnel , Practice Guidelines as Topic , Virus Diseases/diagnosis , Virus Latency , Chickenpox/drug therapy , Chickenpox/virology , Cytomegalovirus Infections/drug therapy , Cytomegalovirus Infections/virology , HIV Infections/drug therapy , HIV Infections/immunology , HIV Infections/virology , HIV-1 , Hepatitis B/drug therapy , Hepatitis B/virology , Hepatitis C/drug therapy , Hepatitis C/virology , Herpes Simplex/drug therapy , Herpes Simplex/virology , Humans , Laboratories , Virus Diseases/drug therapy , Virus Diseases/virology
16.
Euro Surveill ; 7(12): 174-80, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12631983

ABSTRACT

A local sentinel network of general practitioners has been established in the north west of England for the surveillance of influenza. In the 2001-02 winter, consultation rates for influenza-like-illness (ILI) were low but the surveillance network was able to demonstrate sub-regional variations in the timing of peak influenza activity, and the infection of different age groups. This suggests the network can contribute to better planning to winter pressures on the North West health service.


Subject(s)
Family Practice/statistics & numerical data , Influenza, Human/epidemiology , Adolescent , Adult , Age Distribution , Aged , Child , Child, Preschool , England/epidemiology , Female , Humans , Influenza, Human/virology , Male , Middle Aged , Seasons , Sentinel Surveillance , Sex Distribution , Survival Rate , Wales/epidemiology
17.
Transplantation ; 71(11): 1609-15, 2001 Jun 15.
Article in English | MEDLINE | ID: mdl-11435973

ABSTRACT

BACKGROUND: Quantitative assessment of cytomegalovirus (CMV) infection using the antigenemia test has been used to monitor CMV infection in heart and lung transplant patients enabling a preemptive treatment strategy. However, the method is labour intensive, samples have to be processed within a few hours and requires skilled interpretation. A comparative prospective evaluation of a real-time TaqMan CMV quantitative PCR (QPCR) with the CMV antigenemia was undertaken. METHODS: A real-time quantitative TaqMan CMV PCR from EDTA bloods was developed. In this study 25 heart transplant and single-lung transplant patients were monitored posttransplantation by antigenemia and TaqMan CMV QPCR. CMV DNA extracted from EDTA blood was amplified by TaqMan QPCR using primers and probe designed from the CMV glycoprotein B (gB) gene. Quantification of the genome copies is extrapolated from a standard curve generated from amplification of quantified standards. RESULTS: Antigenaemia levels and TaqMan CMV QPCR genome copies showed a linear correlation between the two assays (R=0.843, P=0.001). A clinically significant threshold of 50 CMV pp65 antigen positive polymorphonuclear leucocytes (PMNLs) per 200 000 cells previously reported was used to extrapolate an equivalent value of 40 000 (log 4.6) genome copies per ml of blood for the TaqMan CMV QPCR. CONCLUSIONS: The TaqMan system enables a rapid high-throughput of samples. The TaqMan CMV QPCR can be used as an accurate and robust alternative to the antigenemia test to predict CMV disease and to monitor effectiveness of treatment.


Subject(s)
Antigens, Viral/blood , Cytomegalovirus/immunology , Cytomegalovirus/isolation & purification , Heart-Lung Transplantation , Polymerase Chain Reaction/methods , Viral Load , Computer Systems , Cytomegalovirus Infections/virology , Humans , Postoperative Period , Reproducibility of Results , Sensitivity and Specificity , Time Factors
18.
QJM ; 94(7): 373-8, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11435633

ABSTRACT

Antibiotics are frequently administered for exacerbations of chronic obstructive pulmonary disease and asthma, yet their role remains unclear. We prospectively audited the antimicrobial management of 167 patients aged >50 years hospitalized for exacerbations of chronic airflow limitation. Antibiotics were commenced on admission for 151 (90%) patients (oral 52%, intravenous 38%), including 17/23 (74%) with no evidence of fever, purulent sputum, leucocytosis or inflammatory chest X-ray changes. The mean number of different antibiotics prescribed was 1.8 (range 0-6); a wide range of antibiotics and antibiotic combinations were used. Sputum samples were sent for microbiological examination in 101 (61%) patients. Sputum culture was positive in 34, but only 11 (7% of the total) had amoxycillin-resistant organisms in their sputum. Seventeen patients (10%) developed diarrhoea while in hospital. Under logistic regression analysis, total number of antibiotics prescribed (p<0.0001) and age (p=0.0062) were the two factors associated with hospital-acquired diarrhoea. Only 34% of patients had received an influenza vaccination in the winter of the study, and 10% a pneumococcal vaccination within the last 5 years. In routine clinical practice, aggressive antibiotic therapy was frequently administered to patients admitted with chronic airflow limitation, despite limited clinical, radiological and microbial indications. Excessive use of antibiotics has important implications, including morbidity (antibiotic-associated diarrhoea), cost and the potential for increased microbial antibiotic resistance. A minority of patients with chronic airflow limitation are being vaccinated against influenza and Pneumococcus.


Subject(s)
Anti-Infective Agents/therapeutic use , Lung Diseases, Obstructive/drug therapy , Medical Audit , Acute Disease , Aged , Aged, 80 and over , Anti-Bacterial Agents , Diarrhea/chemically induced , Drug Therapy, Combination/therapeutic use , Female , Humans , Influenza Vaccines/therapeutic use , Length of Stay , Lung Diseases, Obstructive/microbiology , Male , Middle Aged , Penicillin Resistance , Pneumococcal Vaccines/therapeutic use , Practice Patterns, Physicians' , Prospective Studies , Risk Factors , Sputum/microbiology
19.
Bone Marrow Transplant ; 27(3): 301-6, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11277178

ABSTRACT

Potential risk factors for CMV infection and the use of quantitative CMV PCR screening to guide pre-emptive anti-CMV therapy were reviewed retrospectively in 32 allogeneic bone marrow transplant patients accrued over a 2-year period. Significant CMV PCR positivity (an indicator of CMV infection) developed in 34% of patients. When analysed by recipient CMV IgG serostatus, 69% of seropositive recipients developed significant CMV PCR positivity while none of the seronegative recipients did so (P = 0.00007). Considering only the seropositive recipients, 100% of those who received the low intensity campath-1H/fludarabine/melphalan 'mini-allograft' conditioning regimen developed significant CMV PCR positivity, while only 44% of those who had received cyclophosphamide/TBI did so (P = 0.0337). The mean time to first episode of significant CMV PCR positivity for those who had received campath/fludarabine/melphalan was 25 days while for those who had received cyclophosphamide/TBI, this was 66 days (P = 0.0372). For the first episode of significant CMV PCR positivity, the mean index and peak CMV PCR counts for those who had received campath/fludarabine/melphalan were 4.54 and 5.22 log copies/ml respectively, while for cyclophosphamide/TBI, the corresponding figures were 3.85 and 4.12 log copies/ml respectively (P = 0.2986 and P = 0.0472 for index and peak values). 85% of those who had significant CMV PCR positivity with the campath/fludarabine/melphalan regimen developed more than one such episode, while 50% of those receiving cyclophosphamide/TBI regimen did so (P = 0.491). Significant CMV PCR positivity was associated with symptoms in a proportion of patients (pyrexia 45%, cough 18%, rise in AST 72%). No patient developed overt CMV disease. CMV PCR is useful for guiding pre-emptive anti-CMV therapy and for monitoring response.


Subject(s)
Bone Marrow Transplantation/adverse effects , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/prevention & control , Adolescent , Adult , Antigens, Viral/blood , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/toxicity , Cytomegalovirus Infections/etiology , Female , Hematologic Neoplasms/complications , Hematologic Neoplasms/therapy , Hematologic Neoplasms/virology , Humans , Male , Mass Screening , Middle Aged , Polymerase Chain Reaction/methods , Retrospective Studies , Risk Factors , Transplantation Conditioning/adverse effects , Transplantation, Homologous/adverse effects
20.
Addiction ; 96(12): 1787-97, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11784471

ABSTRACT

AIMS: To assess prevalence of, and behavioural risk factors for, hepatitis B and C in drug users both in and out of contact with drugs services. DESIGN: Cross-sectional survey of hepatitis B and C prevalence using blood samples and self-completed risk factor questionnaires. PARTICIPANTS: Three hundred and sixty injecting drug users (IDUs) in treatment for their drug use, attending syringe exchange schemes (SES), and not in contact with any services in Wirral and Manchester between 1997 and 1999, for whom test results were available for 334 (hepatitis B) and 341 (hepatitis C). FINDINGS: Hepatitis B prevalence differed between groups, from 19% of those not in contact to 41% of those presenting to request a test (p = 0.040). Prevalence of hepatitis C ranged from 48% (SES) to 62% among those presenting for a test (p = 0.233). After multivariate adjustment, hepatitis B was predicted by prison stays (p = 0.030) and injecting for longer (p = 0.003). For hepatitis C, length of injecting career (p = 0.036), having been to prison (p = 0.034), having injected more than one drug type (p < 0.001) and being female (p = 0.037) predicted infection. Overall, 38% had shared some form of injecting equipment in the previous 4 weeks. People recently starting injecting were more likely to share, and sharing was more likely to occur when injecting with only one other user rather than in larger groups. Those who had previously presented for a hepatitis C test, regardless of the result, were less likely to have recently shared injecting equipment. CONCLUSIONS: Behaviours associated with transmission of hepatitis B and C are common among IDUs. In particular, sharing of injecting equipment was more likely in small groups and in those recently beginning injecting. More broadly, chaotic drug use and time in prison were also risk factors for hepatitis infections. When assessing prevalence of hepatitis B and C, our results suggest that figures cannot be extrapolated from those in service contact to those in the wider drug-using population.


Subject(s)
Hepatitis B, Chronic/etiology , Hepatitis C, Chronic/etiology , Substance Abuse, Intravenous/complications , Adult , Age of Onset , Confidence Intervals , Cross-Sectional Studies , Enzyme-Linked Immunosorbent Assay , Female , Hepatitis B, Chronic/epidemiology , Hepatitis C, Chronic/epidemiology , Humans , Logistic Models , Male , Needle Sharing , Odds Ratio , Patient Acceptance of Health Care , Polymerase Chain Reaction , Prevalence , Prisoners , Risk Factors , Sex Factors , Sexual Behavior , Substance Abuse, Intravenous/epidemiology , Substance Abuse, Intravenous/therapy , United Kingdom/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...